Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe C Ornstein

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Journal of Kidney Cancer and VHL|September 4, 2024
Clinical Outcomes for Metastatic Renal Cell Carcinoma (mRCC) Patients Ineligible for Front-line Clinical TrialsNathan Reynolds, Wei Wei, Kimberly Maroli, et al.
Targeted Oncology|August 11, 2021
A Multi-institutional, Retrospective Analysis of Patients with Metastatic Renal Cell Carcinoma to Bone Treated with Combination Ipilimumab and NivolumabKunal Desai, Landon Brown, Wei Wei, et al.
Clinical Genitourinary Cancer|September 15, 2016
Clinical Effect of Dose Escalation After Disease Progression in Patients With Metastatic Renal Cell CarcinomaMoshe C Ornstein, Laura Wood, Paul Elson, et al.
Eye (London, England)|February 6, 2026
Risk of retinal vein occlusions in patients taking systemic tyrosine kinase inhibitorsNitesh Mohan, Sunil K Srivastava, Chandni Duphare, et al.
Clinical Genitourinary Cancer|August 18, 2020
Implications of the United States Preventive Services Task Force Recommendations on Prostate Cancer Stage MigrationIris Y Sheng, Wei Wei, Yu-Wei Chen, et al.
Journal for Immunotherapy of Cancer|September 14, 2021
Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumabLandon C Brown, Kunal Desai, Wei Wei, et al.
Urologic Oncology|August 23, 2018
The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy eraYu-Wei Chen, Moshe C Ornstein, Laura S Wood, et al.
Targeted Oncology|November 6, 2021
Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with ImmunotherapyIris Y Sheng, Shilpa Gupta, Chandana A Reddy, et al.
Targeted Oncology|August 20, 2022
Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint InhibitorsIris Y Sheng, Shilpa Gupta, Chandana A Reddy, et al.
Journal for Immunotherapy of Cancer|May 18, 2019
A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapyMoshe C Ornstein, Laura S Wood, Brian P Hobbs, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Journal of Kidney Cancer and VHL|September 4, 2024
Clinical Outcomes for Metastatic Renal Cell Carcinoma (mRCC) Patients Ineligible for Front-line Clinical TrialsNathan Reynolds, Wei Wei, Kimberly Maroli, et al.
Targeted Oncology|August 11, 2021
A Multi-institutional, Retrospective Analysis of Patients with Metastatic Renal Cell Carcinoma to Bone Treated with Combination Ipilimumab and NivolumabKunal Desai, Landon Brown, Wei Wei, et al.
Clinical Genitourinary Cancer|September 15, 2016
Clinical Effect of Dose Escalation After Disease Progression in Patients With Metastatic Renal Cell CarcinomaMoshe C Ornstein, Laura Wood, Paul Elson, et al.
Eye (London, England)|February 6, 2026
Risk of retinal vein occlusions in patients taking systemic tyrosine kinase inhibitorsNitesh Mohan, Sunil K Srivastava, Chandni Duphare, et al.
Clinical Genitourinary Cancer|August 18, 2020
Implications of the United States Preventive Services Task Force Recommendations on Prostate Cancer Stage MigrationIris Y Sheng, Wei Wei, Yu-Wei Chen, et al.
Journal for Immunotherapy of Cancer|September 14, 2021
Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumabLandon C Brown, Kunal Desai, Wei Wei, et al.
Urologic Oncology|August 23, 2018
The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy eraYu-Wei Chen, Moshe C Ornstein, Laura S Wood, et al.
Targeted Oncology|November 6, 2021
Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with ImmunotherapyIris Y Sheng, Shilpa Gupta, Chandana A Reddy, et al.
Targeted Oncology|August 20, 2022
Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint InhibitorsIris Y Sheng, Shilpa Gupta, Chandana A Reddy, et al.
Journal for Immunotherapy of Cancer|May 18, 2019
A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapyMoshe C Ornstein, Laura S Wood, Brian P Hobbs, et al.
Pageof 7